Efficacy of variable-particle hyaluronic acid dermal fillers in patients with skin of color: A randomized, evaluator-blinded comparative trial

Dermatologic Surgery

Volumn 36, Issue SUPPL. 1, 2010, Pages 741-749

  Taylor, Susan C ^a   Burgess, Cheryl M ^b   Callender, Valerie D ^c  

^a Society Hill Dermatology   (United States)

^b Center for Dermatology and Dermatologic Surgery   (United States)

^c Callender Skin and Laser Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; HYALURONIC ACID; HYDROQUINONE; PENICILLIN G;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INJECTION VOLUME; DRUG TOLERABILITY; FEMALE; FITZPATRICK SKIN TYPE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INJECTION SITE BURNING; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE REDNESS; INJECTION SITE SCABBING; INJECTION SITE TENDERNESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASOLABIAL FOLD; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK REDUCTION; SCORING SYSTEM; SKIN ABSCESS; SKIN DISEASE; SKIN INFECTION; SKIN NODULE; SKIN PIGMENTATION; WRINKLE; WRINKLE SEVERITY RATING SCALE;

EID: 77951268332     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01552.x     Document Type: Article

References (16)

1. Cosmetic Surgery National Data Bank Statistics 2004. New York: American Society for Aesthetic Plastic Surgery; 2005.
2. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003 29 : 588 595.
3. Taylor S. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 2002 46 (Suppl) : S41 62.
4. Bolognia JL. Disorders of hyperpigmentation. In : Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology.New York: Mosby; 2003. p. 9751004
5. Calderon M, Lawrence WT, Banes AJ. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res 1996 61 : 343 347.
6. Alaish SM, Yager DR, Diegelman RF, Cohen IK. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995 30 : 949 952.
7. Bloom D. Heredity of keloids. A review of the literature and report of a family with multiple keloids in five generations. NY State J Med 1956 56 : 511 518.
8. Keefe J, Wauk L, DeLustro F. Clinical use of injectable bovine collagen: a decade of experience. Clin Mater 1992 9 : 155 162.
9. DeLustro F, Smith ST, Sundsmo J, et al. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987 79 : 581 594.
10. Restylane Prescribing Information, Medicis Aesthetics Inc., 2005.
11. Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized evaluator-blinded clinical trial. Dermatol Surg 2009 35 : 1653 1660.
12. Norlund JJ, Abdel-Malek ZA. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. Prog Clin Biol Res 1988 256 : 219 236.
13. Odunze M, Cohn A, Few JW. Restylane and people of color. Plast Reconstr Surg 2007 120 : 2011 2016.
14. Halder RM, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983 32 : 388 390.
15. Perlane Prescribing Information, Medicis Aesthetics Inc., 2007.
16. Glogau R, Kane M. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg 2008 34 : S105 9.